Fortress Biotech, Inc. (FBIO)
NASDAQ: FBIO · Real-Time Price · USD
1.790
+0.080 (4.68%)
At close: Jun 24, 2025, 4:00 PM
1.820
+0.030 (1.68%)
After-hours: Jun 24, 2025, 7:44 PM EDT

Fortress Biotech Stock Forecast

Stock Price Forecast

The 2 analysts that cover Fortress Biotech stock have a consensus rating of "Strong Buy" and an average price target of $21, which forecasts a 1073.18% increase in the stock price over the next year. The lowest target is $16 and the highest is $26.

Price Target: $21 (+1073.18%)
Analyst Consensus: Strong Buy
Target Low Average Median High
Price $16 $21 $26 $26
Change +793.85% +1073.2% +1352.5% +1352.5%
* Price targets were last updated on Mar 11, 2025.

Analyst Ratings

The average analyst rating for Fortress Biotech stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jan '25Feb '25Mar '25Apr '25May '25Jun '25
Strong Buy 332222
Buy 111110
Hold 000000
Sell 000000
Strong Sell 000000
Total 443332

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Roth MKM
Roth MKM
Strong Buy
Reiterates
$15$16
Strong Buy Reiterates $15$16 +793.85% Mar 11, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$24$26
Strong Buy Maintains $24$26 +1,352.51% Nov 18, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$24
Strong Buy Reiterates $24 +1,240.78% Jul 19, 2024
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterates
n/a
Buy Reiterates n/a n/a Jun 20, 2024
Roth MKM
Roth MKM
Strong Buy
Reiterates
$10
Strong Buy Reiterates $10 +458.66% May 16, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
87.43M
from 57.68M
Increased by 51.59%
Revenue Next Year
126.54M
from 87.43M
Increased by 44.74%
EPS This Year
-1.43
from -2.69
EPS Next Year
-0.84
from -1.43
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
45.60M68.79M75.74M84.51M57.68M87.43M126.54M202.78M
Revenue Growth
24.49%50.86%10.11%11.58%-31.76%51.59%44.74%60.25%
EPS
-9.69-11.88-15.97-8.47-2.69-1.43-0.84-0.47
EPS Growth
--------
Forward PE
--------
No. Analysts
-----553
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202520262027
High 108.2M 154.1M 208.7M
Avg 87.4M 126.5M 202.8M
Low 67.0M 99.3M 194.8M

Revenue Growth

Revenue Growth 202520262027
High
87.7%
76.3%
65.0%
Avg
51.6%
44.7%
60.2%
Low
16.1%
13.6%
54.0%

EPS Forecast

EPS 202520262027
High -1.26 -0.47 -0.48
Avg -1.43 -0.84 -0.47
Low -1.57 -1.18 -0.45

EPS Growth

EPS Growth 202520262027
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.